NCT07017413

Brief Summary

This prospective cohort study aims to identify clinical and anatomical predictors for complications following transosseous maxillary sinus lift procedures using the Versah (Densah burs) technique. The study focuses on patients undergoing transcrestal sinus floor elevation without a lateral window, with or without simultaneous dental implant placement. Variables such as residual bone height, sinus membrane thickness, bone density, and patient-related factors are being evaluated. The objective is to enhance risk stratification and optimize treatment planning for transosseous sinus augmentation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2025

Completed
Last Updated

June 12, 2025

Status Verified

June 1, 2025

Enrollment Period

11 months

First QC Date

May 25, 2025

Last Update Submit

June 3, 2025

Conditions

Keywords

Transosseous sinus liftVersah sinus liftSchneiderian membrane perforationResidual bone height RBHMaxillary sinusDensah burImplant surgery complicationsRisk predictors sinus elevationMSSMdecision tree

Outcome Measures

Primary Outcomes (1)

  • Composite incidence of maxillary sinus membrane perforation and graft displacement, and identification of associated predictors

    This primary outcome assesses the intraoperative occurrence of Schneiderian membrane perforation and graft displacement during transosseous maxillary sinus lift. It also involves the identification of anatomical and surgical predictors, including residual bone height (RBH), maxillary sinus ostium patency, sinus membrane thickness, surgical site, and the amount of vertical lift performed.

    Intraoperative phase to 1 month post-surgery

Secondary Outcomes (1)

  • Postoperative Infection Rate

    Within 3 months postoperatively

Study Arms (1)

Transosseous Sinus Lift Group

EXPERIMENTAL

Patients will undergo transcrestal maxillary sinus lift using the Versah® osseodensification technique. This arm aims to evaluate the predictors of surgical complications, including residual bone height (RBH), maxillary sinus ostium (MSO) status, Schneiderian membrane thickness, surgical site (tooth location), and amount of vertical lifting required.

Procedure: Transosseous Maxillary Sinus Lift using Osseodensification

Interventions

A surgical procedure utilizing the Versah® osseodensification technique for transcrestal sinus floor elevation. The approach involves the use of specialized Densah® burs to prepare the osteotomy and elevate the sinus membrane through a transosseous (crestal) access, avoiding the lateral window technique. No grafting materials will be used in this procedure.

Transosseous Sinus Lift Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring dental implants in the posterior maxilla with a residual bone height of \< 6 mm.
  • Good general health and absence of systemic conditions affecting bone healing (e.g., uncontrolled diabetes, osteoporosis).
  • No history of chronic sinusitis or other significant sinus pathologies

You may not qualify if:

  • Severe periodontal disease. 2- Residual bone height \> 6 mm. 3- History of previous sinus lift procedures or other maxillofacial surgeries. 4- Smokers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

College of Dentistry , University of Baghdad

Baghdad, Bab Almodaum, 1214, Iraq

RECRUITING

Planto clinic

Baghdad, Mansour, 1456, Iraq

RECRUITING

Related Publications (1)

  • Huwais S, Meyer EG. A Novel Osseous Densification Approach in Implant Osteotomy Preparation to Increase Biomechanical Primary Stability, Bone Mineral Density, and Bone-to-Implant Contact. Int J Oral Maxillofac Implants. 2017 Jan/Feb;32(1):27-36. doi: 10.11607/jomi.4817. Epub 2016 Oct 14.

Central Study Contacts

Mustafa Al-Jamal, BDS, MSc, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No masking is used as both the clinician and the patient are aware of the intervention being performed.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: All enrolled patients will undergo transosseous maxillary sinus lift using the Versah Densah bur technique. Outcomes and predictors of intraoperative and postoperative complications will be assessed within this cohort.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
BDS, MSc OMFS

Study Record Dates

First Submitted

May 25, 2025

First Posted

June 12, 2025

Study Start

November 30, 2024

Primary Completion

October 30, 2025

Study Completion

December 12, 2025

Last Updated

June 12, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to ethical considerations and to maintain patient confidentiality. Data will only be used for the purposes of this study and will not be made publicly available.

Locations